Publications by authors named "Hugo Hok Him Pui"
Diabetes Metab
August 2024
Article Synopsis
- The study looked at how two types of diabetes medicines, SGLT2I and DPP4I, affect the risk of prostate cancer in men with type-2 diabetes.
- Researchers found that men using SGLT2I had a lower chance of getting prostate cancer compared to those using DPP4I.
- This suggests that SGLT2I might be a safer option for men with type-2 diabetes when it comes to the risk of developing prostate cancer.
